top of page
Innovative architecture in Europe

Shaping the Future
of Digital Healthcare

Seed & Early Growth European Digital Health Business Angel

4

million € sales

170 k

people impacted

partnerships with world class players

5

Astrazeneca logo white no background
American hospital of Neuilly logo white no background
Viatris logo white no background
Bristol Myers Squibb logo white no background
Hopital Paris saint Joesph Marie-Lannelongue

Portfolio Highlights

Doctors looking through a microscope to find a diagnostic

Target

Our Focus Areas

We bring our expertise to carefully selected investment sectors, developing the industry's future and redefining what is possible. 

01

AI Research

Cutting-edge services including AI-based Discovery, Decentralized Clinical Trials, innovative CDMO solutions like Cell & Gene Therapy, and pioneering Digital Therapeutics.

AI in drug discovery / Decentralised trials

Scientific research into finding a solution

02

Patient Care

We focus on transformative investments in healthcare, encompassing Acute Care in hospitals, Treatment Initiation & Observance, Chronic Treatment innovations, and initiatives for Quality Aging, aiming to elevate patient care and outcomes across all stages of life.

Acute care, Chronic care

Patient care in a hospital

03

AI Diagnostics

Our investment strategy targets the forefront of medical technology, including AI-based diagnostics, advanced AI imaging, Digital MedTech innovations, and the pioneering field of Predictive Medicine, all designed to revolutionize patient care and health outcomes.

AI imaging, Digital MedTech

Brain scans of a sick patient trying to find a cure
  1. Applied prevention | 20% of people under 20
  2. Fertility | 40% of couple soon in need of assisted procreation
  3. Chronic patients treatment support | 70% of diseases are chronic
  4. Neurologic disease treatment | 20% above 65
  5. Quality aging | 25% of population by 2040

01

Entrepreneurs

  • Invest in teams aligned with our vision and purpose

  • Foster a movement rooted in our respective countries

  • Aim to scale operations across Europe

02

AI4all

  • Advocate for spreading new models through widespread access to AI, tech knowledge, and STEM studies

  • Fund scholarships and enable student access to the ecosystem

03

Diversity

  • Value diversity among entrepreneurs and startups for enhanced growth

  • Commit to maintaining gender balance in investment decisions

04

Investor Persona

  • Share a vision for healthcare innovation that revolutionises current models

  • Support entrepreneurs that invent rather than optimise

Water under a microscope

Qynapse

AI-powered & proprietary neuroimaging software

65788a2bea278a154ae98a93_Walk -p-1600.jpg

Hands-free walk exoskeleton

Wandercraft

Vegetation surrounding futuristic architecture

Non-invasive sensors, software, data science & AI services

Hexoskin

Monitoring Room

Personalised Health Monitoring

Malo

People kayaking in a a rainforest

Founders

Laurent 

Van Lerberghe

Dr. Sandrine 
Van Lerberghe

MBA Insead, Commercial Engineer

Former Chief Strategy Officer Sanofi

& VP Commercial Abbott

Healthcare C-Suite Executive

Investor in Digital Health
 

​

Doctor, Specialist in Endocrinology from University Descartes Paris
DU nutrition Nancy University
Hôpital Antoine-Béclère
 

Preparing bold scale up across Europe

bottom of page